1
Published 2018
CADTH
...CADTH common drug review pharmacoeconomic review report for Akynzeo...

2
Published 2018
CADTH
...CADTH common drug review pharmacoeconomic review report for Akynzeo...

3
Published 2015
Canadian Agency for Drugs and Technologies in Health
...Common drug review...

4
Published 2015
Canadian Agency for Drugs and Technologies in Health
...Common drug review...

5
Published 2015
Canadian Agency for Drugs and Technologies in Health
... cytoplasm antibody (ANCA)- associated vasculitis (AAV) variants. The most common severe manifestation...

6
Published 2015
Canadian Agency for Drugs and Technologies in Health
... cytoplasm antibody (ANCA)- associated vasculitis (AAV) variants. The most common severe manifestation...